Cite
APA Citation
Tomcik, M., Reich, N., Palumbo-Zerr, K., Zerr, P., Avouac, J., Distler, A., Robinson, J., Dees, C., Beyer, C., Becvar, R., Senolt, L., Distler, O., Schett, G., & Distler, J. (n.d.). sAT0025 Antifibrotic effects of imatinib mesylate are not superior to selective inhibition of PDGFR by ARRY-768 in preclinical models of dermal fibrosis. Annals of the rheumatic diseases, 71, 479. http://access.bl.uk/ark:/81055/vdc_100135181703.0x000057